Based on publicly available RNA-seq datasets from the GTEx and TCGA breast invasive carcinoma, we found that KLF9 expression is significantly downregulated in tumor samples in comparison to normal tissue controls (Fig. 1A). The gene discussed is KLF9; the disease is neoplasm.